Cyon

About Cyon

Driven by the knowledge that better outcomes in SEPSIS are possible, Cyon Therapeutics Inc. was formed in 2014 to make this a reality. Led by a team of outstanding Critical Care Physicians and support by 2 CEOs, the goal of the organisation is to bring a novel treatment platform to sepsis. Through their groundbreaking scientific discoveries the team is developing the means to boost the body’s natural ability to clear infectious toxins from the bloodstream.
YEAR FOUNDED:
2014
LEADERSHIP:
Founders: James Russell, Keith Walley, and John Boyd
CEO: John Boyd